Lymphoblastic Lymphoma Clinical Trials

81 clinical trials for Lymphoblastic Lymphoma across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma — RECRUITING · PHASE2
• A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) — RECRUITING · PHASE2
• Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL) — RECRUITING · NA
• Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant — RECRUITING · PHASE2
• A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant — RECRUITING · PHASE1
• First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. — RECRUITING · PHASE1
• Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma — RECRUITING · PHASE2
• Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias — RECRUITING · PHASE1
• Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma — RECRUITING · PHASE4
• CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT — RECRUITING · NA
• Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia — RECRUITING · NA
• Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders — RECRUITING · PHASE2
• CAYA Cancer Prospective Cohort Study — RECRUITING
• Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies — RECRUITING · PHASE2
• Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment — RECRUITING
• MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing — RECRUITING · NA
• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies — RECRUITING · PHASE2
• A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) — RECRUITING · PHASE1
• Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — RECRUITING · PHASE2
• CAYA Cancer Retrospective Cohort Study — RECRUITING
• Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — RECRUITING · PHASE1
• Vitamin A and D Supplementation in Allogeneic HCT — RECRUITING · PHASE2
• BeFluBu vs FluBuRux Conditioning in Haploidentical HCT — RECRUITING · PHASE2
• A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors — ACTIVE_NOT_RECRUITING · NA
• Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma — ACTIVE_NOT_RECRUITING · PHASE2
• Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma — ACTIVE_NOT_RECRUITING · PHASE3
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD — COMPLETED · PHASE2
• Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases — TERMINATED · NA
• Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders — ACTIVE_NOT_RECRUITING
• High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma — ACTIVE_NOT_RECRUITING · NA
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma — TERMINATED · PHASE3
• LBL-2016 for Children or Adolescents in China — ACTIVE_NOT_RECRUITING · PHASE3
• Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment — COMPLETED · PHASE3
• Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL — COMPLETED · PHASE1
• A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy — COMPLETED · PHASE1
• Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) — COMPLETED · PHASE1
• Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease — COMPLETED · PHASE2
• A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of PD5K3 in Healthy Adult Volunteers — COMPLETED · PHASE1
• Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) — COMPLETED · PHASE2
• Expanded Access to Navitoclax — TERMINATED
• SARS-CoV-2 Donor-Recipient Immunity Transfer — COMPLETED
• Allo HSCT Using RIC for Hematological Diseases — COMPLETED · PHASE2
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma — COMPLETED · PHASE1
• Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma — COMPLETED · PHASE1
• Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies — COMPLETED · PHASE1
• Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia — COMPLETED · PHASE1
• Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults — COMPLETED · PHASE4

Refine this search